Rezultati

eNauka >  Rezultati >  CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability
Naziv: CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability
Autori: Joković, Danilo; Milosavljević, Filip  ; Stojanović, Zvezdana  ; Šupić, Gordana  ; Vojvodić, Danilo  ; Uzelac, Bojana; Jukić, Marin  ; Petković Ćurčin, Aleksandra  
Godina: 2022
Publikacija: Psychiatry Research
ISSN: 0165-1781 Psychiatry Research Pretraži identifikator
Izdavač: Limerick : Elsevier/North-Holland Biomedical Press
Tip rezultata: Naučni članak
Kolacija: vol. 312 br. (114535) str. 114535-114535
DOI: 10.1016/j.psychres.2022.114535
WoS-ID: 000821199300009
Scopus-ID: 2-s2.0-85127725861
URI: https://enauka.gov.rs/handle/123456789/465219
https://farfar.pharmacy.bg.ac.rs/handle/123456789/4080
Projekat: PsyCise - Utility of Plasma Drug Level Monitoring and Cyp2c19/Cyp2d6 Genotyping in Dose Personalization of Antidepressants and Antipsychotics (RS-6066800)
MFVMA/05/20–22 grant from the University of Defense, Belgrade, Serbia
M-kategorija: 
21aM21a - Rad u međ. časopisu izuzetnih vrednosti

4
SCOPUSTM
1
OpenCitations
5
WEB OF SCIENCETM
Alt metrika
Dimensions

Pronađi DOI

Unpaywall

Creative Commons licenca